L Trademark

Trademark Overview

On Thursday, June 6, 2024, a trademark application was filed for L with the United States Patent and Trademark Office. The USPTO has given the L trademark a serial number of 98587976. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, October 28, 2025. This trademark is owned by Lymphoma Research Foundation. The L trademark is filed in the Insurance & Financial Services category with the following description:

Funding Research In The Nature of Providing Grants In The Field Of Lymphoma; And Charitable Fundraising In The Field Of Lymphoma
l

General Information

Serial Number98587976
Word MarkL
Filing DateThursday, June 6, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, October 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 1, 2025

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesFunding Research In The Nature of Providing Grants In The Field Of Lymphoma; And Charitable Fundraising In The Field Of Lymphoma
Description of MarkThe mark consists of a stylized "L".

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLymphoma Research Foundation
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNew York, NY 10005
Party NameLymphoma Research Foundation
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew York, NY 10006

Trademark Events

Event DateEvent Description
Thursday, June 6, 2024NEW APPLICATION ENTERED
Wednesday, December 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 19, 2024ASSIGNED TO EXAMINER
Friday, December 27, 2024NON-FINAL ACTION WRITTEN
Friday, December 27, 2024NON-FINAL ACTION E-MAILED
Friday, December 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 3, 2025NON-FINAL ACTION WRITTEN
Monday, March 3, 2025NON-FINAL ACTION E-MAILED
Monday, March 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 5, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 5, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 5, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 8, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 1, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 1, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, May 2, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 2, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 2, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 27, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 28, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, October 28, 2025SOU EXTENSION 1 FILED
Tuesday, October 28, 2025SOU EXTENSION 1 GRANTED
Wednesday, October 29, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 29, 2025TEAS STATEMENT OF USE RECEIVED

Related Keywords

field lymphoma fundraising charitable grants research nature providing funding